Senior Specialist II, QA Systems and Training

OXB; North East; On-site; GBP 50,000 - 70,000; Full time

Job summary

A leading biopharmaceutical company in the North East of England is seeking a Senior Specialist II for QA Systems and Training. This role involves managing the Learning Management System and improving training compliance and effectiveness. Ideal candidates will have a Bachelor's in Life Sciences and 5+ years of experience in the biopharmaceutical industry. A commitment to continuous improvement and collaboration is essential. Join us to help deliver life-changing therapies.

Benefits

Competitive total reward packages

Wellbeing programs

Career development opportunities

Collaborative culture

State-of-the-art labs

Qualifications

• Minimum of 5 years’ experience in the pharmaceutical or biopharmaceutical industry.
• Strong experience managing training programs in a regulated environment.
• Expert knowledge of LMS and EDMS; Veeva experience preferred.

Responsibilities

• Manage day-to-day operations of the site Learning Management System (LMS).
• Partner with functional areas to assess training compliance.
• Support development of training materials and knowledge assessments.

Skills

Communication

Interpersonal skills

Organizational skills

Attention to detail

Collaboration

Education

Bachelor’s degree in Life Sciences

Tools

Learning Management Systems (LMS)

Electronic Document Management Systems (EDMS)

Microsoft Office

Job description

Overview

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

Following the expansion of our US footprint with the acquisition of a new commercial-scale viral vector facility in Durham, North Carolina we have some new opportunities to join us. We’re currently recruiting for a Senior Specialist II, QA Systems and Training to join our Quality Assurance team. In this role, you’ll play a key part in driving compliance excellence and learning culture across the site. You will oversee the day-to-day operations of our Learning Management System (LMS), support training program development, and partner with cross-functional teams playing a key part in advancing our mission and making a real difference.

Your Responsibilities

• Manage day-to-day operations of the site Learning Management System (LMS), including auditing, reporting, and compliance monitoring.
• Partner with functional areas to assess training compliance, perform effectiveness checks, and track trends.
• Support development of training materials and knowledge assessments for key processes and systems.
• Lead annual curriculum audits and provide guidance to department leaders.
• Deliver site Good Documentation Practice (GDP) training and refresher sessions.
• Create and maintain site-level curricula, job aids, and training documentation.
• Serve as LMS super-user and point of contact for user training and external stakeholders.
• Support line management with project coordination, review of training content, and oversight of annual GMP training.
• Contribute to QA systems support, audits, and regulatory inspections.
• Monitor training program effectiveness and identify opportunities for continuous improvement.

We Are Looking For

• Bachelor’s degree in Life Sciences
• Minimum of 5 years’ experience in the pharmaceutical or biopharmaceutical industry (CDMO/GMP)
• Strong experience leading or managing training programs within a regulated environment.
• Expert knowledge of Learning Management Systems (LMS) and Electronic Document Management Systems (EDMS); Veeva experience preferred.
• Excellent communication, interpersonal, and organizational skills, with ability to collaborate effectively across global teams.
• Proficiency in Microsoft Office and document publishing software (e.g., Excel, Adobe Pro).
• Proactive, detail-oriented, and able to manage multiple priorities in a fast-paced environment.

This role does not offer sponsorship for work authorization. External applicants must be eligible to work in the United States.

About Us

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors—the driving force behind the majority of gene therapies. We collaborate with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Our world-class capabilities span from early-stage development to commercialisation, supported by robust quality-assurance systems, analytical methods, and regulatory expertise.

Why Join Us?

• Competitive total reward packages
• Wellbeing programs that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State-of-the-art labs and manufacturing facilities
• A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.